Citation | Zehnder, L; Bennett, M; Meng, J; Huang, B; Ninkovic, S; Wang, F; Braganza, J; Tatlock, J; Jewell, T; Zhou, JZ; Burke, B; Wang, J; Maegley, K; Mehta, PP; Yin, MJ; Gajiwala, KS; Hickey, MJ; Yamazaki, S; Smith, E; Kang, P; Sistla, A; Dovalsantos, E; Gehring, MR; Kania, R; Wythes, M; Kung, PP Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyr J Med Chem54:3368-85 (2011) [PubMed] Article |
---|
SMILES | CC(C)(CCOc1cc(Cl)cc(Cl)c1-c1nc(N)nc2CN(Cc12)C(=O)NC1CCC1)C#N |(43.48,-32.31,;44.26,-33.65,;45.02,-32.31,;42.93,-34.43,;41.59,-33.66,;40.26,-34.44,;40.27,-35.98,;41.6,-36.74,;41.61,-38.29,;42.95,-39.06,;40.28,-39.06,;38.94,-38.29,;37.61,-39.06,;38.94,-36.75,;37.62,-35.99,;36.28,-36.76,;34.95,-35.99,;33.61,-36.75,;34.95,-34.44,;36.28,-33.67,;36.59,-32.17,;38.12,-32,;38.75,-33.4,;37.61,-34.43,;38.88,-30.66,;38.11,-29.33,;40.42,-30.66,;41.19,-29.32,;42.66,-28.92,;42.26,-27.43,;40.77,-27.84,;45.6,-34.42,;46.93,-35.17,)| |